Welcome!

News Feed Item

iSpecimen Closes $8 Million in Financing

OneBlood Partnership helps iSpecimen Meet Need for Human Biospecimens

LEXINGTON, Mass., Sept. 4, 2014 /PRNewswire/ -- iSpecimen®, a provider of on-demand human biospecimens to the life science community, announced today that it has secured $8 million in capital in its Series B Financing. New investor OneBlood™, Inc., through a wholly owned subsidiary, in conjunction with existing investors, will help grow iSpecimen's healthcare partner network and scale operations to meet the ever increasing needs of its research customers for annotated human biospecimens.

iSpecimen brings together sophisticated technology and professional service solutions to meet the needs of today's medical research community. The company provides customized specimen collections, along with rich clinical data, to help researchers increase the speed of bringing new drugs and diagnostics to market.

Every year, life scientists spend billions of dollars procuring millions of human specimens for their research programs. Typically, this involves procuring specimens along with limited clinical data from biobanks or sponsoring research to gain access to specific patients and their clinical history but at considerable time and expense. iSpecimen simplifies the process of finding the right specimens from specific patient populations by partnering with healthcare providers, gaining access to their laboratory specimens and patient-level data, and matching these against research needs.

Using its own novel technology that searches de-identified medical records for precise patient characteristics and their associated specimens, iSpecimen instructs healthcare partners to pick and ship these specimens to its research customers instead of discarding them as is typically done after clinical testing has been completed. 

"This is an incredibly exciting time in the evolution of iSpecimen.  Since raising our first round of financing we've expanded our partner network to include dozens of healthcare facilities, implemented our technology and proven that it can match researchers' needs to available specimens," said Christopher Ianelli, MD, PhD, Founder and Chief Executive Officer of iSpecimen.  "We have introduced the idea of using technology to connect researchers to specific patients and their specimens and are thrilled that OneBlood, along with our existing investors, believes in iSpecimen's vision.  We look forward to their invaluable strategic guidance as we expand our operations to provide specimens to even more researchers worldwide," said Ianelli.

"The synergies between OneBlood and iSpecimen are plentiful. Both organizations are developing cutting-edge advances in medical science and opening the door to innovative clinical research. These realities make the partnership between the two organizations a natural one," said Bud Scholl, Chief Strategy and Integration Officer for OneBlood. "By being proactive and investing in new and emerging technologies and platforms of service today, we enhance our ability to further develop avenues that provide additional cost savings to our hospital partners and their patients," said Scholl.

Founded in 2009, iSpecimen is a pioneer in the use of technology to search electronic health records along with laboratory information systems to find specific patients and specimens in order to repurpose them into research. The company currently provides access to millions of patients and their discarded specimens yearly to its customers in industry, government and academia.

About OneBlood

OneBlood is a not-for-profit 501(c)(3) community asset responsible for providing safe, available and affordable blood to more than 200 hospital partners and their patients throughout most of Florida and into parts of South Georgia and Alabama.

OneBlood was established on January 27, 2012 when three of Florida's independent, not-for-profit blood centers merged. Together, OneBlood brings more than 100 years of lifesaving experience to the community. OneBlood collects nearly one million units of blood annually, employs approximately 2,000 people, operates more than 70 donor centers and deploys nearly 200 of its signature Big Red Buses throughout its service area for blood drives.  To learn more about OneBlood, please visit www.oneblood.org.

About iSpecimen

iSpecimen, a privately held company, provides life scientists with a rich source of high-quality human biospecimens for their research and development programs. The company's pioneering technology allows it to search through millions of patient specimens flowing through its partner network of healthcare facilities each year to find biospecimens based on associated laboratory and medical record data. These samples, most of which would otherwise be discarded after clinical testing, exactly match patient cohort criteria and provide a steady supply of richly-annotated human biospecimens for a variety of basic and translational research. For more information about iSpecimen, please visit www.ispecimen.com.

SOURCE iSpecimen

More Stories By PR Newswire

Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Latest Stories
Financial Technology has become a topic of intense interest throughout the cloud developer and enterprise IT communities. Accordingly, attendees at the upcoming 20th Cloud Expo at the Javits Center in New York, June 6-8, 2017, will find fresh new content in a new track called FinTech.
Whether your IoT service is connecting cars, homes, appliances, wearable, cameras or other devices, one question hangs in the balance – how do you actually make money from this service? The ability to turn your IoT service into profit requires the ability to create a monetization strategy that is flexible, scalable and working for you in real-time. It must be a transparent, smoothly implemented strategy that all stakeholders – from customers to the board – will be able to understand and comprehe...
Keeping pace with advancements in software delivery processes and tooling is taxing even for the most proficient organizations. Point tools, platforms, open source and the increasing adoption of private and public cloud services requires strong engineering rigor – all in the face of developer demands to use the tools of choice. As Agile has settled in as a mainstream practice, now DevOps has emerged as the next wave to improve software delivery speed and output. To make DevOps work, organization...
"Qosmos has launched L7Viewer, a network traffic analysis tool, so it analyzes all the traffic between the virtual machine and the data center and the virtual machine and the external world," stated Sebastien Synold, Product Line Manager at Qosmos, in this SYS-CON.tv interview at 19th Cloud Expo, held November 1-3, 2016, at the Santa Clara Convention Center in Santa Clara, CA.
In his keynote at 18th Cloud Expo, Andrew Keys, Co-Founder of ConsenSys Enterprise, provided an overview of the evolution of the Internet and the Database and the future of their combination – the Blockchain. Andrew Keys is Co-Founder of ConsenSys Enterprise. He comes to ConsenSys Enterprise with capital markets, technology and entrepreneurial experience. Previously, he worked for UBS investment bank in equities analysis. Later, he was responsible for the creation and distribution of life sett...
The WebRTC Summit New York, to be held June 6-8, 2017, at the Javits Center in New York City, NY, announces that its Call for Papers is now open. Topics include all aspects of improving IT delivery by eliminating waste through automated business models leveraging cloud technologies. WebRTC Summit is co-located with 20th International Cloud Expo and @ThingsExpo. WebRTC is the future of browser-to-browser communications, and continues to make inroads into the traditional, difficult, plug-in web co...
Successful digital transformation requires new organizational competencies and capabilities. Research tells us that the biggest impediment to successful transformation is human; consequently, the biggest enabler is a properly skilled and empowered workforce. In the digital age, new individual and collective competencies are required. In his session at 19th Cloud Expo, Bob Newhouse, CEO and founder of Agilitiv, drew together recent research and lessons learned from emerging and established compa...
Without lifecycle traceability and visibility across the tool chain, stakeholders from Planning-to-Ops have limited insight and answers to who, what, when, why and how across the DevOps lifecycle. This impacts the ability to deliver high quality software at the needed velocity to drive positive business outcomes. In his general session at @DevOpsSummit at 19th Cloud Expo, Phil Hombledal, Solution Architect at CollabNet, discussed how customers are able to achieve a level of transparency that e...
WebRTC is the future of browser-to-browser communications, and continues to make inroads into the traditional, difficult, plug-in web communications world. The 6th WebRTC Summit continues our tradition of delivering the latest and greatest presentations within the world of WebRTC. Topics include voice calling, video chat, P2P file sharing, and use cases that have already leveraged the power and convenience of WebRTC.
"Coalfire is a cyber-risk, security and compliance assessment and advisory services firm. We do a lot of work with the cloud service provider community," explained Ryan McGowan, Vice President, Sales (West) at Coalfire Systems, Inc., in this SYS-CON.tv interview at 19th Cloud Expo, held November 1-3, 2016, at the Santa Clara Convention Center in Santa Clara, CA.
Get deep visibility into the performance of your databases and expert advice for performance optimization and tuning. You can't get application performance without database performance. Give everyone on the team a comprehensive view of how every aspect of the system affects performance across SQL database operations, host server and OS, virtualization resources and storage I/O. Quickly find bottlenecks and troubleshoot complex problems.
Regulatory requirements exist to promote the controlled sharing of information, while protecting the privacy and/or security of the information. Regulations for each type of information have their own set of rules, policies, and guidelines. Cloud Service Providers (CSP) are faced with increasing demand for services at decreasing prices. Demonstrating and maintaining compliance with regulations is a nontrivial task and doing so against numerous sets of regulatory requirements can be daunting task...
Extracting business value from Internet of Things (IoT) data doesn’t happen overnight. There are several requirements that must be satisfied, including IoT device enablement, data analysis, real-time detection of complex events and automated orchestration of actions. Unfortunately, too many companies fall short in achieving their business goals by implementing incomplete solutions or not focusing on tangible use cases. In his general session at @ThingsExpo, Dave McCarthy, Director of Products...
20th Cloud Expo, taking place June 6-8, 2017, at the Javits Center in New York City, NY, will feature technical sessions from a rock star conference faculty and the leading industry players in the world. Cloud computing is now being embraced by a majority of enterprises of all sizes. Yesterday's debate about public vs. private has transformed into the reality of hybrid cloud: a recent survey shows that 74% of enterprises have a hybrid cloud strategy.
Businesses and business units of all sizes can benefit from cloud computing, but many don't want the cost, performance and security concerns of public cloud nor the complexity of building their own private clouds. Today, some cloud vendors are using artificial intelligence (AI) to simplify cloud deployment and management. In his session at 20th Cloud Expo, Ajay Gulati, Co-founder and CEO of ZeroStack, will discuss how AI can simplify cloud operations. He will cover the following topics: why clou...